A Johns Hopkins symposium brought together researchers, clinicians, and the public for a discussion about the future of COVID-19 vaccines and therapeutics.
The November 20 symposium, “COVID-19 Symposium at Hopkins: Navigating the pandemic when effective vaccines are in the policy toolbox,” was hosted by the Hopkins Business of Health Initiative and featured Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, as the keynote speaker.
Fauci’s address first walked the audience through the epidemiology, virology, and clinical manifestations of the virus. He then turned his focus to emerging therapeutics, including the promising Pfizer and Moderna vaccines, calling them “extraordinarily good news.”
“We know what the efficacy of the vaccines is, but [their] effectiveness will depend on how many people take the vaccine,” Fauci said, noting that many citizens continue to feel skeptical about science and vaccines.
Despite the success of any vaccine and public health measures, pandemics are here to stay, Fauci said.
“We’ve always had pandemics. We are living through a historic one now. And there will be ones in the future,” he said.
Fauci urged the attendees to “retain our corporate memory” and not make the same mistakes when confronted with the next pandemic.
His analysis was followed by two panel discussions.